Diagnostic value of myocardial radionuclide imaging in patients with multivessel coronary disease.

Background: Myocardial perfusion radionuclide imaging (MPRI) is a noninvasive method extremely useful for evaluating ischemia in patients with coronary disease. However, the idea that this method would not be effective for patients with multivessel coronary disease is still entertained.

Objective: Assess the value of MPRI with gated-SPECT for tracing pharmacological stress-induced ischemia in patients with multivessel obstructive coronary disease.